Genmab — August 2020
-
Kesimpta
(ofatumumab) approved by U.S. FDA for the treatment of relapsing forms of multiple sclerosis in adults
First B-cell therapy that can be self-administered using Sensoready autoinjector pen
Approval based on Phase III ASCLEPIOS I and II studies -
Ved ikke hvor meget højere det kan blive. Men Genmab fik taget dem i røveren (GSK), idet rygterne vil vide, at Genmab fik retten til at arbejde med stoffer rettet imod CD20 igen i forbindelse med overdragelsen af Arzerra til Novartis. Det kan vi være glade for i dag.
technologies
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind